Gilder Gagnon Howe & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,679
| Closed | -$814K | – | 258 |
|
2025
Q1 | $814K | Sell |
1,679
-28
| -2% | -$13.6K | 0.01% | 192 |
|
2024
Q4 | $687K | Sell |
1,707
-333
| -16% | -$134K | 0.01% | 226 |
|
2024
Q3 | $949K | Sell |
2,040
-27
| -1% | -$12.6K | 0.01% | 211 |
|
2024
Q2 | $969K | Buy |
2,067
+273
| +15% | +$128K | 0.01% | 207 |
|
2024
Q1 | $750K | Sell |
1,794
-20
| -1% | -$8.36K | 0.01% | 225 |
|
2023
Q4 | $738K | Buy |
+1,814
| New | +$738K | 0.01% | 216 |
|